---
input_text: 'The Efficacy of Noninvasive Ventilation in Patients Affected by Rett
  Syndrome With Hypoventilation. BACKGROUND: Rett syndrome is a progressive neurological
  disorder associated to several comorbidities that contribute significantly to impair
  lung function. Respiratory morbidity represents a major cause of death in this population.
  Little is known about the benefit of noninvasive ventilation. METHODS: We retrospectively
  enrolled patients with Rett syndrome who underwent a pneumological evaluation combined
  with a cardiorespiratory polygraphy and/or a pulse oximetry and capnography from
  2012 to 2022. RESULTS: Medical records of 11 patients with Rett syndrome, mean age
  13 +- 6 years, were evaluated. Most patients presented with both epilepsy and scoliosis.
  Five patients showed a pathologic sleep study and/or impaired night gas exchange:
  mean obstructive apnea-hypopnea index was 4 +- 3 events/hour; mean and minimal SpO2
  were, respectively, 93% +- 2% and 83% +- 6%, while mean and maximal transcutaneous
  carbon dioxide monitoring (PtcCO2) were, respectively, 51 +- 5 mm Hg and 55 +- 8
  mm Hg; and mean oxygen desaturation index was 13 +- 11 events/hour. These patients
  started noninvasive ventilation with clinical benefit and improved gas exchange
  mostly in terms of PtcCO2 (mean PtcCO2 51 +- 5 mm Hg before and 46 +- 6 mm Hg after
  noninvasive ventilation). CONCLUSIONS: Noninvasive ventilation is a suitable option
  for patients with Rett syndrome.'
raw_completion_output: |-
  primary_disease: Rett Syndrome
  medical_actions: Noninvasive ventilation;Pneumological evaluation;Cardiorespiratory polygraphy;Pulse oximetry;Capnography
  symptoms: Hypoventilation;Pathologic sleep study;Impaired night gas exchange;Obstructive apnea-hypopnea;Low SpO2;High transcutaneous carbon dioxide monitoring (PtcCO2);Oxygen desaturation
  chemicals: 
  action_annotation_relationships: Noninvasive ventilation TREATS Hypoventilation IN Rett Syndrome;Noninvasive ventilation TREATS Pathologic sleep study IN Rett Syndrome;Noninvasive ventilation TREATS Impaired night gas exchange IN Rett Syndrome;Noninvasive ventilation TREATS Obstructive apnea-hypopnea IN Rett Syndrome;Noninvasive ventilation TREATS Low SpO2 IN Rett Syndrome;Noninvasive ventilation TREATS High transcutaneous carbon dioxide monitoring (PtcCO2) IN Rett Syndrome;Noninvasive ventilation TREATS Oxygen desaturation IN Rett Syndrome
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Noninvasive ventilation TREATS Oxygen desaturation IN Rett Syndrome

  ===

extracted_object:
  primary_disease: MONDO:0010726
  medical_actions:
    - MAXO:0000506
    - Pneumological evaluation
    - Cardiorespiratory polygraphy
    - MAXO:0000617
    - Capnography
  symptoms:
    - HP:0002791
    - Pathologic sleep study
    - Impaired night gas exchange
    - Obstructive apnea-hypopnea
    - Low SpO2
    - High transcutaneous carbon dioxide monitoring (PtcCO2)
    - Oxygen desaturation
  action_annotation_relationships:
    - subject: MAXO:0000506
      predicate: TREATS
      object: HP:0002791
      qualifier: MONDO:0010726
    - subject: MAXO:0000506
      predicate: TREATS
      object: Pathologic sleep study
      qualifier: MONDO:0010726
    - subject: MAXO:0000506
      predicate: TREATS
      object: Impaired night gas exchange
      qualifier: MONDO:0010726
    - subject: MAXO:0000506
      predicate: TREATS
      object: Obstructive apnea-hypopnea
      qualifier: MONDO:0010726
    - subject: MAXO:0000506
      predicate: TREATS
      object: Low SpO2
      qualifier: MONDO:0010726
    - subject: MAXO:0000506
      predicate: TREATS
      object: High transcutaneous carbon dioxide monitoring (PtcCO2)
      qualifier: MONDO:0010726
    - subject: <Noninvasive ventilation>
      predicate: <TREATS>
      object: <Oxygen desaturation>
      qualifier: <Rett Syndrome>
      subject_qualifier: <None>
      object_qualifier: <None>
      subject_extension: <None>
      object_extension: <None>
named_entities:
  - id: MONDO:0005647
    label: Genital warts
  - id: MONDO:0002602
    label: Central nervous system diseases
  - id: HP:0002011
    label: central nervous system diseases
  - id: MONDO:0010726
    label: Rett syndrome
  - id: MONDO:0005027
    label: epilepsy
  - id: HP:0001250
    label: seizures
  - id: MAXO:0001298
    label: therapy
  - id: HP:0002186
    label: apraxia
  - id: HP:0002333
    label: motor deterioration
  - id: CHEBI:229599
    label: Trofinetide
  - id: HP:0012444
    label: Brain atrophy
  - id: CHEBI:182159
    label: Cannabidivarin (CBDV)
  - id: HP:0012531
    label: Pain
  - id: MAXO:0001001
    label: Gene therapy
  - id: HP:0002540
    label: inability to walk
  - id: HP:0002300
    label: inability to speak
  - id: HP:0000787
    label: Nephrolithiasis
  - id: HP:0000016
    label: Urinary retention
  - id: MAXO:0000759
    label: HPV vaccination
  - id: MAXO:0000790
    label: Breast examinations
  - id: MAXO:0000793
    label: Pelvic examinations
  - id: HP:0100543
    label: Cognitive dysfunction
  - id: MONDO:0100039
    label: CDKL5 disorder
  - id: MAXO:0009101
    label: Early intervention
  - id: CHEBI:176843
    label: Vitamin B12
  - id: CHEBI:16347
    label: Levocarnitine
  - id: CHEBI:26708
    label: NA
  - id: CHEBI:7421
    label: N-acetyl cysteine (NAC)
  - id: CHEBI:46895
    label: LPS
  - id: CHEBI:17561
    label: L-cysteine
  - id: HP:0002360
    label: Sleep disturbances
  - id: MAXO:0000458
    label: Hydrotherapy
  - id: MAXO:0000011
    label: Physical therapy
  - id: HP:0001251
    label: Ataxia
  - id: CHEBI:75883
    label: Magnetic Nanoparticle-Assisted Genome Editing (MAGE)
  - id: MONDO:0005560
    label: Brain Disorders
  - id: HP:0001298
    label: Brain Disorders
  - id: HP:0002376
    label: developmental regression
  - id: HP:0000708
    label: Behavioural problems
  - id: HP:0002607
    label: Bowel incontinence
  - id: HP:0002094
    label: Breathing difficulties
  - id: HP:0002019
    label: Constipation
  - id: HP:0011968
    label: Feeding difficulties
  - id: HP:0000020
    label: Urinary incontinence
  - id: MONDO:0001071
    label: Intellectual disability
  - id: CHEBI:3638
    label: Chloroquine
  - id: MAXO:0000943
    label: Forniceal deep brain stimulation (DBS)
  - id: HP:0002354
    label: Memory impairment
  - id: CHEBI:191875
    label: denoising source separation (DSS) algorithm
  - id: CHEBI:4806
    label: Epigallocatechin gallate (EGCG)
  - id: CHEBI:27881
    label: Resveratrol
  - id: CHEBI:46245
    label: Coenzyme Q10 (CoQ10)
  - id: CHEBI:176783
    label: Vitamin C
  - id: CHEBI:33234
    label: Vitamin E
  - id: CHEBI:15422
    label: ATP
  - id: CHEBI:13389
    label: NAD
  - id: CHEBI:15996
    label: GTP
  - id: CHEBI:16856
    label: GSH
  - id: CHEBI:17858
    label: GSSG
  - id: CHEBI:566274
    label: Malondialdehyde (MDA)
  - id: MAXO:0001394
    label: Oral administration
  - id: HP:0025464
    label: Oxidative stress
  - id: MONDO:0700092
    label: Neurodevelopmental disorders (NDDs)
  - id: MONDO:0006664
    label: Autism Spectrum Disorder (ASD) and related neurogenetic syndromes
  - id: MAXO:0000506
    label: Noninvasive ventilation
  - id: MAXO:0000617
    label: Pulse oximetry
  - id: HP:0002791
    label: Hypoventilation
